18.77USD+0.16%Mkt Cap: 712.18M USDP/E: —Last update: 2026-05-22
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the ac…
Industry Peers
Medical Devices152.25BUSDP/E 24.5
85.88BUSDP/E 24.2
53.45BSEKP/E 22.7
53.33BSEKP/E 98.9
52.13BDKKP/E 22.1
38.61BEURP/E 18.3
23.15BSEK—
22.25BEURP/E 23.4
loading…
Indicators:|
Key Statistics
Company
Market Cap712.18M USD
Enterprise Value591.98M USD
Revenue (TTM)95.07M USD
Gross Profit78.27M USD
Net Income (TTM)-53.41M USD
Revenue/Share2.570 USD
Last Price18.77 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees327
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-17.06
PEG—
EV/EBITDA-9.29
EV/Revenue6.23
P/S7.48
P/B5.04
EPS (TTM)-1.62
EPS (Forward)-1.10
52W Range
10.8559% of range24.33
52W High24.33 USD
52W Low10.85 USD
Profitability
Gross Margin87.89%
Oper. Margin-78.30%
EBITDA Margin-67.00%
Profit Margin-59.97%
ROE-34.38%
ROA-27.28%
Growth
Revenue Growth29.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-40.81M USD
CapEx (TTM)767.00K USD
FCF Margin-30.86%
FCF Yield-4.12%
Net Debt-119.07M USD
Net Debt/EBITDA1.87
Balance Sheet
Debt/Equity0.14
Current Ratio10.44
Quick Ratio9.70
Book Value/Sh3.719 USD
Cash/Share3.721 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)26.86 USD
Target Range24.00 USD – 32.00 USD
# Analysts7
Ownership
Shares Out.37.94M
Float25.86M
Insiders12.78%
Institutions86.78%
Short Interest
Short Ratio7.4d
Short % Float7.68%
Short % Out.4.98%
Shares Short1.88M
Short (prev mo.)1.88M
Technical
SMA 5019.15 (-2.0%)
SMA 20016.90 (+11.1%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)321.24K
Avg Vol (10d)485.26K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—